Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà
MedNavigator.ru - Ïîèñê è ïîäáîð ëå÷åíèÿ â Ðîññèè è çà ðóáåæîì

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Ãåìàòîëîãèÿ è òðàíñôóçèîëîãèÿ

Îòâåò
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #1  
Ñòàðûé 05.10.2013, 18:18
tanya2505 tanya2505 âíå ôîðóìà Ïîë æåíñêèé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 05.10.2013
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 16
Ñêàçàë(à) ñïàñèáî: 2
tanya2505 *
Íèçêèé ãåìîãëîáèí, âûñîêèé óðîâåíü òðîìáîöèòîâ

Äîáðûé äåíü. Ïîìîãèòå, ïîæàëóéñòà, ñ ðåçóëüòàòàìè àíàëèçîâ.
Ïîë æåíñêèé, âîçðàñò 45 ëåò, ðîñò 165, âåñ 52. Æàëîáû íà ñëàáîñòü.
Òåðàïåâò íàïðàâèë íà óçè áðþøíîé ïîëîñòè (âñå â íîðìå) è àíàëèçû êðîâè íà îíêîëîãèþ (ïîêà íå ãîòîâû). Æäåì èõ ñ óæàñîì...êàæåòñÿ, ïîñåäåëè çà ýòè íåñêîëüêî äíåé. Çàðàíåå áîëüøîå ñïàñèáî.
Âñå ïîêàçàòåëè â íîðìå, êðîìå ýòèõ:
Ãåìîãëîáèí 85,37 (117-160)
Ãåìàòîêðèò 32,96 (35-47)
Ñðåäíèé îáúåì ýðèòðîöèòîâ, fl 63,98 (81-101)
Ñð. ñîä. ãåìîãëîá. â ýð-òå, pg 16,57 (27-34)
Ñð. êîíö. ãåìîãëîá. â ýð-òå, ã/ë 259,00 (310-360)
Òðîìáîöèòû, 10'9/ë 496,60 (150-350)
Îòâåòèòü ñ öèòèðîâàíèåì
  #2  
Ñòàðûé 06.10.2013, 15:37
tanya2505 tanya2505 âíå ôîðóìà Ïîë æåíñêèé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 05.10.2013
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 16
Ñêàçàë(à) ñïàñèáî: 2
tanya2505 *
Ïðèøëè äîïîëíèòåëüíûå àíàëèçû. Îíêîìàðêåðû â íîðìå. Âñå ïîêàçàòåëè â íîðìå êðîìå ýòèõ:
Ôåððèòèí 5,09 (10120)
Âèòàìèí Â12 777,3 (191-663)
ÎÆÑÑ 96,9 (44,80-80,60)
Æåëåçî 7,5 (9,00-30,40)
Îòâåòèòü ñ öèòèðîâàíèåì
  #3  
Ñòàðûé 06.10.2013, 19:39
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,394
Ïîáëàãîäàðèëè 33,236 ðàç(à) çà 31,585 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ó æåíùèíû - áàíàëüíàÿ æåëåçîäåôèöèòíàÿ àíåìèÿ, êîòîðóþ ñëåäóåò êîððåêòèðîâàòü ïðåïàðàòîì æåëåçà è âèò. Ñ, â ðàöèîíå - óâåëè÷èòü êîëè÷åñòâî áåëêà è ìÿñíûõ áëþä
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #4  
Ñòàðûé 06.10.2013, 20:17
tanya2505 tanya2505 âíå ôîðóìà Ïîë æåíñêèé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 05.10.2013
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 16
Ñêàçàë(à) ñïàñèáî: 2
tanya2505 *
Öèòàòà:
Ñîîáùåíèå îò Dr.Vad Ïîñìîòðåòü ñîîáùåíèå
Ó æåíùèíû - áàíàëüíàÿ æåëåçîäåôèöèòíàÿ àíåìèÿ, êîòîðóþ ñëåäóåò êîððåêòèðîâàòü ïðåïàðàòîì æåëåçà è âèò. Ñ, â ðàöèîíå - óâåëè÷èòü êîëè÷åñòâî áåëêà è ìÿñíûõ áëþä
Îãðîìíîå ñïàñèáî çà îòâåò! À â ÷åì ìîæåò áûòü ïðè÷èíà? Íàñ íàïðàâèëè íà ãàñòðîñêîïèþ è êîëîíîñêîïèþ.
Îòâåòèòü ñ öèòèðîâàíèåì
  #5  
Ñòàðûé 06.10.2013, 20:50
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,394
Ïîáëàãîäàðèëè 33,236 ðàç(à) çà 31,585 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
â 45 ëåò - ÷àøå âñåãî îáèëüíûå ìåñÿ÷íûå ïëþñ ïëîõîå óñâîåíèå æåëåçà èç ÆÊÒ (àòðîôè÷. ãàñòðèò?, õåëèêîáàêò. èíôåêöèÿ?).
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #6  
Ñòàðûé 09.10.2013, 11:26
tanya2505 tanya2505 âíå ôîðóìà Ïîë æåíñêèé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 05.10.2013
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 16
Ñêàçàë(à) ñïàñèáî: 2
tanya2505 *
Öèòàòà:
Ñîîáùåíèå îò Dr.Vad Ïîñìîòðåòü ñîîáùåíèå
â 45 ëåò - ÷àøå âñåãî îáèëüíûå ìåñÿ÷íûå ïëþñ ïëîõîå óñâîåíèå æåëåçà èç ÆÊÒ (àòðîôè÷. ãàñòðèò?, õåëèêîáàêò. èíôåêöèÿ?).
Åùå ðàç ñïàñèáî. Îêàçàëñÿ õðîíè÷åñêèé ïàíãàñòðèò.
Îòâåòèòü ñ öèòèðîâàíèåì
  #7  
Ñòàðûé 09.10.2013, 20:54
tanya2505 tanya2505 âíå ôîðóìà Ïîë æåíñêèé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 05.10.2013
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 16
Ñêàçàë(à) ñïàñèáî: 2
tanya2505 *
Öèòàòà:
Ñîîáùåíèå îò Dr.Vad Ïîñìîòðåòü ñîîáùåíèå
â 45 ëåò - ÷àøå âñåãî îáèëüíûå ìåñÿ÷íûå ïëþñ ïëîõîå óñâîåíèå æåëåçà èç ÆÊÒ (àòðîôè÷. ãàñòðèò?, õåëèêîáàêò. èíôåêöèÿ?).
Âàäèì Âàëåðüåâè÷, âðà÷è ïðîäîëæàþò íàñ êîøìàðèòü. Âðà÷ ñêàçàëà, ÷òî ïðè òàêîì ãàñòðèòå íå ìîæåò òàê óïàñòü ãåìîãëîáèí. Îòïðàâèëè íà ÊÒ áðþøíîé ïîëîñòè, òàì íàøëè èçìåíåíèÿ â ïå÷åíè (êèñòà è ÷òî-òî åùå), íî âðà÷ ñêàçàë, ÷òî ê ãåìîãëîáèíó ýòî îòíîøåíèÿ íå èìååò è íà îíêî íå ïîõîæå, íî íà âñÿêèé ñëó÷àé íóæíî ê îíêîëîãó. Ðåçóëüòàòû èññëåäîâàíèÿ ïðèëàãàþ. Ïîìîãèòå, ïîæàëóéñòà.
Îòâåòèòü ñ öèòèðîâàíèåì
  #8  
Ñòàðûé 09.10.2013, 20:55
tanya2505 tanya2505 âíå ôîðóìà Ïîë æåíñêèé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 05.10.2013
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 16
Ñêàçàë(à) ñïàñèáî: 2
tanya2505 *
ïðîäîëæåíèå
Îòâåòèòü ñ öèòèðîâàíèåì
  #9  
Ñòàðûé 09.10.2013, 21:44
tanya2505 tanya2505 âíå ôîðóìà Ïîë æåíñêèé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 05.10.2013
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 16
Ñêàçàë(à) ñïàñèáî: 2
tanya2505 *
àíàëèçû êðîâè. åùå ñäàí êàë íà ñêðûòóþ êðîâü, êðîâü íå âûÿâëåíà.
Îòâåòèòü ñ öèòèðîâàíèåì
  #10  
Ñòàðûé 09.10.2013, 22:30
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,394
Ïîáëàãîäàðèëè 33,236 ðàç(à) çà 31,585 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ïîêàæèòå ñâîåìó âðà÷ó äàííóþ ðàáîòó èç Èçðàèëÿ, ãäå ïðè÷èíû ÆÄÀ èñêàëèñü ó 116 æåíùèí îò 18 äî 45 ëåò:

Clinically, significant lesions were demonstrated in 30%, the majority in the upper gastrointestinal tract. Helicobacter pylori gastritis was the most common finding (16%). Celiac disease was detected in 6%. No malignant lesions were detected. The prevalence of lesions was highest among women with symptoms of heartburn and regurgitation. The presence of upper gastrointestinal symptoms (OR: 3.67, 95%CI: 2.14-5.03; P = 0.002), MCV lower than 70 pg (OR: 1.88, 95%CI: 1.27-3.91; P = 0.04), and hemoglobin levels less than 10 g/dl (OR: 1.71, 95%CI: 1.19-4.07; P = 0.05) were associated with an increased likelihood of significant gastrointestinal lesions; history of heavy menstrual blood loss was associated with negative findings (OR: 0.46, 95%CI: 0.27-0.69; P = 0.002).

Dig Dis Sci. 2008 Dec;53(12):3138-44.
Prevalence and predictive signs for gastrointestinal lesions in premenopausal women with iron deficiency anemia.
Carter D, Maor Y, Bar-Meir S, Avidan B.

ó êàæäîé òðåòüåé - ïðîáëåìû ñ ÆÊÒ (õåëèêîáàêò. ãàñòðèò ó êàæäîé 6-îé) è ÍÈ îäíîãî ñëó÷àÿ çëîêà÷åñòâ. îáðàçîâàíèÿ. Ñðåäíèé îáúåì ýðèòðîöèòîâ ìåíåå 70 ïëþñ ãåìîãëîáèí ìåíåå 100 ïîâûøàëè ðèñê îáíàðóæåíèÿ ïðîáëåì ñ ÆÊÒ â 3 ðàçà. Âðîäå áû Ìîñêâà - îãðîìíûé ãîðîä, à Âû îáðàùàåòåñü ê êàêèì-òî ñëàáîãðàìîòíûì âðà÷àì.
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #11  
Ñòàðûé 09.10.2013, 22:44
tanya2505 tanya2505 âíå ôîðóìà Ïîë æåíñêèé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 05.10.2013
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 16
Ñêàçàë(à) ñïàñèáî: 2
tanya2505 *
Öèòàòà:
Ñîîáùåíèå îò Dr.Vad Ïîñìîòðåòü ñîîáùåíèå
Ïîêàæèòå ñâîåìó âðà÷ó äàííóþ ðàáîòó èç Èçðàèëÿ, ãäå ïðè÷èíû ÆÄÀ èñêàëèñü ó 116 æåíùèí îò 18 äî 45 ëåò:

Clinically, significant lesions were demonstrated in 30%, the majority in the upper gastrointestinal tract. Helicobacter pylori gastritis was the most common finding (16%). Celiac disease was detected in 6%. No malignant lesions were detected. The prevalence of lesions was highest among women with symptoms of heartburn and regurgitation. The presence of upper gastrointestinal symptoms (OR: 3.67, 95%CI: 2.14-5.03; P = 0.002), MCV lower than 70 pg (OR: 1.88, 95%CI: 1.27-3.91; P = 0.04), and hemoglobin levels less than 10 g/dl (OR: 1.71, 95%CI: 1.19-4.07; P = 0.05) were associated with an increased likelihood of significant gastrointestinal lesions; history of heavy menstrual blood loss was associated with negative findings (OR: 0.46, 95%CI: 0.27-0.69; P = 0.002).

Dig Dis Sci. 2008 Dec;53(12):3138-44.
Prevalence and predictive signs for gastrointestinal lesions in premenopausal women with iron deficiency anemia.
Carter D, Maor Y, Bar-Meir S, Avidan B.

ó êàæäîé òðåòüåé - ïðîáëåìû ñ ÆÊÒ (õåëèêîáàêò. ãàñòðèò ó êàæäîé 6-îé) è ÍÈ îäíîãî ñëó÷àÿ çëîêà÷åñòâ. îáðàçîâàíèÿ. Ñðåäíèé îáúåì ýðèòðîöèòîâ ìåíåå 70 ïëþñ ãåìîãëîáèí ìåíåå 100 ïîâûøàëè ðèñê îáíàðóæåíèÿ ïðîáëåì ñ ÆÊÒ â 3 ðàçà. Âðîäå áû Ìîñêâà - îãðîìíûé ãîðîä, à Âû îáðàùàåòåñü ê êàêèì-òî ñëàáîãðàìîòíûì âðà÷àì.
Ñïàñèáî çà îòâåò. Ïðîáëåì â òîì, ÷òî áîëüøèíñòâî ìîñêîâñêèõ âðà÷åé õîòÿò "çàëå÷èòü" âñå, ÷òî òîëüêî ìîæíî è íàéòè êàê ìîæíî áîëüøå ïðîáëåì, ÷òîáû áûëî íà ÷åì çàðàáîòàòü. Ïîýòîìó ïðèõîäèòñÿ âñå ïåðåïðîâåðÿòü...
Ñåãîäíÿ íàì ñêàçàëè, ÷òî ó íàñ ÷òî-òî "íåîáû÷íîå è èíòåðåñíîå, íî íà îíêîëîãèþ âðîäå íå ïîõîæå". Çàêëþ÷åíèå äàëè òàêîå: ÊÒ êàðòèíà îáðàçîâàíèÿ ëåâîé äîëè ïå÷åíè (äèôôåðåíöèðîâàòü ãèïîâàñêóëÿðíîå îáðàçîâàíèå è ëîêàëüíûé ñòåàòîç ëåâîé äîëè), íåáîëüøîé êèñòû ëåâîé äîëè. ×òî ýòî ìîæåò áûòü?
Èç ëå÷åíèÿ íàì âûïèñàëè Äå-Íîë, Íåêñèóì è Ñîðáèôåð.
Îòâåòèòü ñ öèòèðîâàíèåì
  #12  
Ñòàðûé 09.10.2013, 22:49
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,394
Ïîáëàãîäàðèëè 33,236 ðàç(à) çà 31,585 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ñïðàøèâàòü íóæíî òîãî, êòî âèäåë ÊÒ âîî÷èþ è ìîæåò ïðîâåñòè äèôô. äèàãíîñòèêó, èñïîëüçóÿ äîï. ìåòîäû, à òàê ìîãó ïîâòîðèòü, ÷òî óæå íàïèñàíî: èëè ãèïîâàñêóëÿðíîå îáðàçîâàíèå, èëè ëîêàëüíûé ñòåàòîç. Íà ôîíå íàçíà÷åíèÿ íåêñèóìà ñîðáèôåð ïëîõî óñâàèâàåòñÿ - æåíùèíó ëó÷øå ïîêàçàòü Ñïåöèàëèñòó, à íå ñëó÷àéíîìó ÷åëîâåêó îò ìåäèöèíû, îäåòîìó â áåëûé õàëàò...
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #13  
Ñòàðûé 06.11.2013, 07:43
tanya2505 tanya2505 âíå ôîðóìà Ïîë æåíñêèé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 05.10.2013
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 16
Ñêàçàë(à) ñïàñèáî: 2
tanya2505 *
Âàäèì Âàëåðüåâè÷, äîáðûé äåíü. Çà 3 íåäåëè ëå÷åíèÿ ãåìîãëîáèí ïîäíÿëñÿ äî 109, îñòàëüíûå ïîêàçàòåëè òîæå óëó÷øèëèñü. Íî, æàëóåòñÿ íà áîëè â ñóñòàâàõ, ïîòëèâîñòü ïî íî÷àì (íåðâíè÷àåò ïî ýòîìó ïîâîäó, ïîòîìó ÷òî ñ÷èòàåò, ÷òî îíà ïîòååò ïî íî÷àì òîëüêî êîãäà áîëååò, ñîîòâåñòâåííî, îíà ÷åì-òî áîëååò, íî íå çíàåò îá ýòîì...), ãîëîâîêðóæåíèå. Ñ ÷åì ýòî ìîæåò áûòü ñâÿçàíî? Íóæíî ëè ïðîéòè äîïîëíèòåëüíîå îáñëåäîâàíèå (ùèòîâèäêà, ëåãêèå è ïå÷åíü â íîðìå)?
Îòâåòèòü ñ öèòèðîâàíèåì
  #14  
Ñòàðûé 06.11.2013, 16:57
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,394
Ïîáëàãîäàðèëè 33,236 ðàç(à) çà 31,585 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
ïðîäîëæàéòå ëå÷åíèå ïîêà ãåìîãëîáèí íå ñòàíåò áîëåå 125 ïëþñ åøå 3-4 ìåñ., åñëè ïî îêîí÷àíèè ëå÷åíèÿ êàêèå èç ñèìïòîìîâ îñòàíóòñÿ, òîãäà áóäåòå îáñëåäîâàòüñÿ
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #15  
Ñòàðûé 08.11.2013, 13:10
tanya2505 tanya2505 âíå ôîðóìà Ïîë æåíñêèé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 05.10.2013
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 16
Ñêàçàë(à) ñïàñèáî: 2
tanya2505 *
Öèòàòà:
Ñîîáùåíèå îò Dr.Vad Ïîñìîòðåòü ñîîáùåíèå
ïðîäîëæàéòå ëå÷åíèå ïîêà ãåìîãëîáèí íå ñòàíåò áîëåå 125 ïëþñ åøå 3-4 ìåñ., åñëè ïî îêîí÷àíèè ëå÷åíèÿ êàêèå èç ñèìïòîìîâ îñòàíóòñÿ, òîãäà áóäåòå îáñëåäîâàòüñÿ
åùå ðàç ñïàñèáî. ïðèøëè ðåçóëüòàòû êðîâè ïî èññëåäîâàíèþ ïå÷åíè. âñå îòðèöàòåëüíîå è â íîðìå. à ïîêàçàòåëü Anti-HBc-total ïîëîæèòåëüíûé. ýòî ãîâîðèò î íàëè÷èè âèðóñà?
Îòâåòèòü ñ öèòèðîâàíèåì
Îòâåò



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 23:30.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.